Adipose tissue-derived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory b cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus

Cell Transplantation

Volumn 24, Issue 11, 2015, Pages 2367-2377

  Park, Min Jung ^a   Kwok, Seung Ki ^a   Lee, Sung Hee ^a   Kim, Eun Kyung ^a   Park, Sung Hwan ^a   Cho, Mi La ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Follicular helper T cells (Tfh cells); Interleukin (IL) 10; Mesenchymal stem cells (MSCs); Regulatory B cells (Bregs); Systemic lupus erythematosus (SLE)

Indexed keywords

INTERLEUKIN 10; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; IL10 PROTEIN, MOUSE; RC3H1 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; COCULTURE; FEMALE; GERMINAL CENTER; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MURINE MODEL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH17 CELL; THERAPY EFFECT; ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; PATHOPHYSIOLOGY; T LYMPHOCYTE;

ADIPOSE TISSUE; ANIMALS; B-LYMPHOCYTES, REGULATORY; DISEASE MODELS, ANIMAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES; UBIQUITIN-PROTEIN LIGASES;

EID: 84945892509     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368914X685645     Document Type: Article

References (35)

1. Asari, S.; Itakura, S.; Ferreri, K.; Liu, C. P.; Kuroda, Y.; Kandeel, F.; Mullen, Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp. Hematol. 37(5):604– 615; 2009.
2. Bernardo, M. E.; Fibbe, W. E. Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders. Ann. N. Y. Acad. Sci. 1266:107–117; 2012.
3. Carter, N. A.; Vasconcellos, R.; Rosser, E. C.; Tulone, C.; Munoz-Suano, A.; Kamanaka, M.; Ehrenstein, M. R.; Flavell, R. A.; Mauri, C. Mice lacking endogenous IL-10producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 186(10):5569–5579; 2011.
4. Choi, E. W.; Shin, I. S.; Park, S. Y.; Park, J. H.; Kim, J. S.; Yoon, E. J.; Kang, S. K.; Ra, J. C.; Hong, S. H. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum. 64(1):243–253; 2012.
5. Corcione, A.; Benvenuto, F.; Ferretti, E.; Giunti, D.; Cappiello, V.; Cazzanti, F.; Risso, M.; Gualandi, F.; Mancardi, G. L.; Pistoia, V.; Uccetlli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107(1):367–372; 2006.
6. Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29:621–663; 2011.
7. De Miguel, M. P.; Fuentes-Julian, S.; Blazquez-Martinez, A.; Pascual, C. Y.; Aller, M. A.; Arias, J.; Arnalich-Montiel, F. Immunosuppressive properties of mesenchymal stem cells: Advances and applications. Curr. Mol. Med. 12(5):574–591; 2012.
8. DelaRosa, O.; Dalemans, W.; Lombardo, E. Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases. Curr. Opin. Biotechnol. 23(6):978–983; 2012.
9. Duffy, M. M.; Ritter, T.; Ceredig, R.; Griffin, M. D. Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res. Ther. 2(4):34; 2011.
10. Gu, F.; Molano, I.; Ruiz, P.; Sun, L.; Gilkeson, G. S. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/ NZW)F1 mice. Clin. Immunol. 145(2):142–152; 2012.
11. Gu, Z.; Akiyama, K.; Ma, X.; Zhang, H.; Feng, X.; Yao, G.; Hou, Y.; Lu, L.; Gilkeson, G. S.; Silver, R. M.; Zeng, X.; Shi, S.; Sun, L. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 19(13):1502–1514; 2010.
12. Jiang, Y.; Jahagirdar, B. N.; Reinhardt, R. L.; Schwartz, R. E.; Keene, C. D.; Ortiz-Gonzalez, X. R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W. C.; Largaespada, D. A.; Verfaillie, C. M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893):41–49; 2002.
13. Krampera, M.; Pasini, A.; Pizzolo, G.; Cosmi, L.; Romagnani, S.; Annunziato, F. Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr. Opin. Pharmacol. 6(4):435–441; 2006.
14. Lenert, P.; Brummel, R.; Field, E. H.; Ashman, R. F. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J. Clin. Immunol. 25(1):29–40; 2005.
15. Liang, J.; Zhang, H.; Hua, B.; Wang, H.; Lu, L.; Shi, S.; Hou, Y.; Zeng, X.; Gilkeson, G. S.; Sun, L. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: A pilot clinical study. Ann. Rheum. Dis. 69(8):1423–1429; 2010.
16. Lin, C. S.; Lin, G.; Lue, T. F. Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev. 21(15):2770–2778; 2012.
17. Linterman, M. A.; Rigby, R. J.; Wong, R. K.; Yu, D.; Brink, R.; Cannons, J. L.; Schwartzberg, P. L.; Cook, M. C.; Walters, G. D.; Vinuesa, C. G. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206(3):561–576; 2009.
18. Lundy, S. K.; Sarkar, S.; Tesmer, L. A.; Fox, D. A. Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res. Ther. 9(1):202; 2007.
19. Mariani, E.; Facchini, A. Clinical applications and biosafety of human adult mesenchymal stem cells. Curr. Pharm. Des. 18(13):1821–1845; 2012.
20. Mauri, C.; Blair, P. A. Regulatory B cells in autoimmunity: Developments and controversies. Nat. Rev. Rheumatol. 6(11):636–643; 2010.
21. Mauri, C.; Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30:221–241; 2012.
22. Nguyen, L. T.; Jacobs, J.; Mathis, D.; Benoist, C. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 56(2):509–520; 2007.
23. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143–147; 1999.
24. Ra, J. C.; Shin, I. S.; Kim, S. H.; Kang, S. K.; Kang, B. C.; Lee, H. Y.; Kim, Y. J.; Jo, J. Y.; Yoon, E. J.; Choi, H. J.; Kwon, E. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 20(8):1297–1308; 2011.
25. Rasmusson, I.; Le Blanc, K.; Sundberg, B.; Ringden, O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand. J. Immunol. 65(4):336–343; 2007.
26. Schena, F.; Gambini, C.; Gregorio, A.; Mosconi, M.; Reverberi, D.; Gattorno, M.; Casazza, S.; Uccelli, A.; Moretta, L.; Martini, A.; Traggiai, E. Interferon-gammadependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum. 62(9):2776–2786; 2010.
27. Spaggiari, G. M.; Abdelrazik, H.; Becchetti, F.; Moretta, L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: Central role of MSC-derived prostaglandin E2. Blood 113(26):6576–6583; 2009.
28. Spaggiari, G. M.; Capobianco, A.; Abdelrazik, H.; Becchetti, F.; Mingari, M. C.; Moretta, L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111(3):1327–1333; 2008.
29. Sun, L.; Wang, D.; Liang, J.; Zhang, H.; Feng, X.; Wang, H.; Hua, B.; Liu, B.; Ye, S.; Hu, X.; Xu, W.; Zeng, X.; Hou, Y.; Gilkeson, G. S.; Silver, R. M.; Lu, L.; Shi, S. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 62(8):2467–2475; 2010.
30. Tangye, S. G.; Ma, C. S.; Brink, R.; Deenick, E. K. The good, the bad and the ugly - TFH cells in human health and disease. Nat. Rev. Immunol. 13(6):412–426; 2013.
31. Vinuesa, C. G.; Cook, M. C.; Angelucci, C.; Athanasopoulos, V.; Rui, L.; Hill, K. M.; Yu, D.; Domaschenz, H.; Whittle, B.; Lambe, T.; Roberts, I. S.; Copley, R. R.; Bell, J. I.; Cornall, R. J.; Goodnow, C. C. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435(7041):452–458; 2005.
32. Yanaba, K.; Bouaziz, J. D.; Haas, K. M.; Poe, J. C.; Fujimoto, M.; Tedder, T. F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28(5):639–650; 2008.
33. Yanaba, K.; Bouaziz, J. D.; Matsushita, T.; Tsubata, T.; Tedder, T. F. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182(12):7459–7472; 2009.
34. Youd, M.; Blickarz, C.; Woodworth, L.; Touzjian, T.; Edling, A.; Tedstone, J.; Ruzek, M.; Tubo, R.; Kaplan, J.; Lodie, T. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clin. Exp. Immunol. 161(1):176–186; 2010.
35. Zhou, K.; Zhang, H.; Jin, O.; Feng, X.; Yao, G.; Hou, Y.; Sun, L. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell. Mol. Immunol. 5(6):417–424; 2008.